Navigation Links
Cambrex Appoints Steven M. Klosk as President and CEO
Date:5/15/2008

EAST RUTHERFORD, N.J., May 15 /PRNewswire-FirstCall/ -- Cambrex (NYSE: CBM), a leading life sciences company, announced today that the Board of Directors appointed Steven M. Klosk, President and Chief Executive Officer and a member of the Cambrex Corporation Board of Directors effective May 14, 2008. James A. Mack, President and Chief Executive Officer since 1995 and Chairman since 1999, has announced he will step down. The Company will separate the positions of Board Chairman and CEO and John R. Miller, currently lead director, will assume the position of Non-Executive Chairman of the Board. Mr. Mack will remain a Board member and advisor until his retirement on June 30, 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20000613/CAMBREXLOGO )

Mr. Klosk, 51, joined Cambrex in October 1992 as Vice President-Administration. He was appointed Executive Vice President, Administration in October 1996, and was promoted to the position of Executive Vice President and Chief Operating Officer for Cambrex Pharma and BioPharmaceutical Business Unit in October 2003. In January 2005 Mr. Klosk assumed direct responsibility for the BioPharmaceutical Business Unit as Chief Operating Officer. In January 2007 he was appointed Executive Vice President and Chief Operating Officer for the Corporation. He holds a Bachelor of Science degree from Cornell University and a J. D. degree from New York Law School.

"I have enjoyed my many years with Cambrex and now is the right time to turn the Company over to new leadership. I am confident that with his many years with Cambrex, Steve will ably continue the pattern of growth that is so much a part of the Company," commented Mr. Mack.

"I am excited about the opportunity to lead the Cambrex team as we focus on our growth initiatives in proprietary products and polymeric drug delivery, highly potent compounds, controlled substances
'/>"/>

SOURCE Cambrex
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Cambrex Presentation at the JPMorgan Healthcare Conference to be Webcast
2. Cambrex to Announce Fourth Quarter and Full Year 2007 Financial Results on February 14, 2008
3. BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
4. Codexis Appoints Singapore Laboratories Managing Director
5. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
6. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. NanoLogix Inc. Appoints Director of IP and Makes Progress on Rapid Anthrax Detection
9. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
10. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
11. NeurogesX Appoints New Director to the Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...Newswire/ -- BioTrends Research Group, Inc.,releas...M) publication, a,syndicated report offering compr...ia and bone and mineral metabolism in Chronic Kidn... information from 182 US,Nephrologists -- data wer...ne 2008., In the renal anemia market, while the u...
(Date:7/25/2008)...X, CALGARY, July 25 / Resv...X:RVX) is pleased to announce effective,immediatel...irectors. On,the subject of her appointment Jan Gr...xciting opportunity for me. The Company has done a...linical trials. I expect the next,foreseeable futu...
(Date:7/25/2008)...swire-FirstCall/ -- Caraco Pharmaceutical,Laborato...first quarter of,Fiscal 2009, ended June 30, 2008,...or the corresponding period of Fiscal 2008. This r...er of Fiscal 2008. Pre-tax income grew,to $14.6 mi...ared to a,pre-tax income of $9.6 million during th...
(Date:7/25/2008)...25 /- REvolution Computing will,lead ...R product at the,upcoming BioC 2008 conference in ... REvolution Computing Director of Community, Dr. D... Training Manager, and Martin Morgan of,the Fred H...ting,s BioC lab,will introduce participants to the...
Breaking Biology Technology:BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 2BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 3Jan Gray Joins Resverlogix Board of Directors 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 3Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 4Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 5Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 6Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 7REvolution Computing Offers Hands-On Tutorial of NWS Parallel Computing Environment at BioC 2008 2
..., Jolanta Kolodziejek, MSc, and Professor ... Group, Institute of Virology, University of Veter...z 1, A 1210 Vienna, Austria , , ... template employed in sequencing PCR (cycle sequen...cleotide sequencing. The presence of , co...
..., Anne-Lise Brresen-Dale, Sigrid Lystad, a...ute for Cancer Research, The,Norwegian Radium Ho...ion , Temporal temperature gradient ele... upon which denaturing gradient gel electropho...l electrophoresis (CDGE) are based. TTGE combines ...
..., Udo Reischl and Christian Gerdes, Instit...ity of Regensburg, 93053 Regensburg, Germany , ...nosis of Epstein-Barr virus (EBV) infection is cur...dies to distinct EBV antigens. In the past few ,...erodiagnostic assay systems , have been c...
..., , Introduction , ... year for use as primers , or probes in g...ions has , traditionally been done by sla... methods may require expensive reagents and labor...ired quantitative precision or automation. Capilla...
Other Biology Technology:Comparison of PCR Kleen Spin Columns to Traditional Methods for Purification of PCR Products Prior to Sequencing, Rev A 2Comparison of PCR Kleen Spin Columns to Traditional Methods for Purification of PCR Products Prior to Sequencing, Rev A 3Comparison of PCR Kleen Spin Columns to Traditional Methods for Purification of PCR Products Prior to Sequencing, Rev A 4TTGE on the DCode System 2TTGE on the DCode System 3TTGE on the DCode System 4Preparative SDS-PAGE Electrophoresis of a Recombinant Epstein-Barr Virus Encoded Protein and Its Application in Serodiagnostic Test Systems, Rev C 2Preparative SDS-PAGE Electrophoresis of a Recombinant Epstein-Barr Virus Encoded Protein and Its Application in Serodiagnostic Test Systems, Rev C 3Preparative SDS-PAGE Electrophoresis of a Recombinant Epstein-Barr Virus Encoded Protein and Its Application in Serodiagnostic Test Systems, Rev C 4Preparative SDS-PAGE Electrophoresis of a Recombinant Epstein-Barr Virus Encoded Protein and Its Application in Serodiagnostic Test Systems, Rev C 5Preparative SDS-PAGE Electrophoresis of a Recombinant Epstein-Barr Virus Encoded Protein and Its Application in Serodiagnostic Test Systems, Rev C 6Preparative SDS-PAGE Electrophoresis of a Recombinant Epstein-Barr Virus Encoded Protein and Its Application in Serodiagnostic Test Systems, Rev C 7Preparative SDS-PAGE Electrophoresis of a Recombinant Epstein-Barr Virus Encoded Protein and Its Application in Serodiagnostic Test Systems, Rev C 8Oligonucleotide Purity Analysis by Capillary Electrophoresis 2Oligonucleotide Purity Analysis by Capillary Electrophoresis 3
(Date:7/24/2008)...am led by Massachusetts General Hospital (MGH) inv...enomic research and medicine a robust method for ...cular DNA sequences for inactivation or repair. ...archers describe an efficient, publicly available ...s (ZFNs), which can be used to induce specific gen...
(Date:7/24/2008)...dy by researchers from Columbia University,s Mailm...st challenging issues in infant health and prevent...ries. In these settings, HIV-infected mothers had...infants, they should exclusively breast-feed, foll...irth. But according to the study conducted in Lusa...
(Date:7/24/2008)...ine researchers have found a molecular link betwee...olism. The discovery reveals new possibilities for...ted diseases. , Paolo Sassone-Corsi, Distinguish...lleagues have identified that an essential protein...rhythms, works in balance with another protein cal...
(Date:7/24/2008)...2008. A fire is currently burning through a study ...or about 2 years ago. Managers used data and analy...R) study in the planning, analysis, and implementa...e is now active., The Gotchen LSR, lies on the e...covers about 15,000 acres of the Mount Adams Range...
Breaking Biology News(10 mins):Consortium develops new method enabling routine targeted gene modification 2Early cessation of breastfeeding by HIV+ women in poor countries and child survival 2Early cessation of breastfeeding by HIV+ women in poor countries and child survival 3Circadian rhythm-metabolism link discovered 2Landscape study may offer solutions for fire managers 2From beach to backyard caution can reduce firepit burns 22960 1From beach to backyard caution can reduce firepit burns 22960 2New electrostatic based DNA microarray technique could revolutionize medical diagnostics 3821 1New electrostatic based DNA microarray technique could revolutionize medical diagnostics 3821 2New electrostatic based DNA microarray technique could revolutionize medical diagnostics 3821 3New electrostatic based DNA microarray technique could revolutionize medical diagnostics 3821 4Tree killing fungus officially named by scientists 3819 1Tree killing fungus officially named by scientists 3819 2Robbins 26 Myers Issues Corrected Conference Call Information 22958 1
...e caused by arterial blockages related to diabetes...ns ?are occurring at an alarming rate. Yet physici...them may be preventable, according to the Internat...nly disfiguring and life-threatening, but are more...on, which is the reestablishment of blood supply. ...
...SX: NRM) is pleased to announce that Neurobiology ... medical journals in the fields of gerontology and...a publication on the preclinical development of tr...ed?, including efficacy results in a mouse model o...sents a potential new class of therapeutic agent a...
...y Professor of Psychology Dr. Jeffrey Mogil shows ...d but unproven even among higher primates, is also... online June 29 in the journal Science, Professor ...lleagues in the Pain Genetics Lab at McGill Univer...t is, familiar to each other) and able to see one ...
...f Texas M. D. Anderson Cancer Center have signific...a cell begins the process of self-destruction - an...argeted cancer therapies. , , In the June 30 is...hat a natural "brake" exists in a cell to prevent ...eath, and they say that optimal anti-cancer therap...
Other Biology News:Epidemic of unneeded amputations 2Tramiprosate (Alzhemed? preclinical results published in Neurobiology of Aging 2Tramiprosate (Alzhemed? preclinical results published in Neurobiology of Aging 3Researchers find molecular 'brake' to cell death 2Researchers find molecular 'brake' to cell death 3
Mouse monoclonal [4i144] to HLA Class II DQ1 7 ( Abpromise for all tested applications). Antigen: Full length protein (Human): HLA Class 2 Antigen DQ1,7.
ASCIZ
Goat polyclonal to CHMP5 ( Abpromise for all tested applications). Antigen: Synthetic peptide: C-NKDGVLVDEFGLPQ, corresponding to C terminal amino acids 202-215 of Human CHMP5 Entrez GeneID:
Custom Oligo Assay Single Locus 1920 samples from Illumina
Biology Products: